The activation of PKD1 and the reduction of β-catenin transcriptional activity by curcumin may also impact androgen receptor (AR) signaling in prostate cancer, since both PKD1 and β-catenin modulate AR function. This evidence concerns the gene PKD1 and prostate cancer.